Neurochemical and behavioral studies on ethanol and brain opiod interactions in the brain
Author: Lindholm, Sara
Date: 2001-10-19
Location: Föreläsningssalen, Magnus Huss, Karolinska Sjukhuset
Time: 9.00
Department: Institutionen för klinisk neurovetenskap / Department of Clinical Neuroscience
Abstract
Substance dependence is a devastating disorder that produces enormous socio-economic costs, personal tragedies and health related problems. The brain mesolimbic dopamine pathway originating in the ventral tegmental area (VTA) with projections to limbic brain structures such as the nucleus accumbens has been implicated in the reinforcing effects of different drugs of abuse. The basal and drug-induced activity of mesolimbic dopamine neurons is modulated by endogenous opioids. Non-selective opioid receptor antagonists are increasingly used in the treatment of alcohol dependence, and ligands selective for the different opioid receptor types have recently been suggested to be effective in the treatment of cocaine and heroin addiction in humans. The present thesis examined the neurobiological and behavioral interactions between ethanol and endogenous opioids, with specific focus on the dynorphin/kappa-opioid receptor system. In addition, the effects of concurrent ethanol and cocaine administration on kappa-opioid receptor mRNA and dopamine transmission in the mesolimbic pathway were studied.
Repeated ethanol administration significantly increased the dynorphin B levels in the nucleus accumbens at 30 min and at 21 days after the last dose. The kappa-receptor mRNA levels were significantly reduced in both the VTA and the nucleus accumbens after separate as well as concurrent administration of ethanol and cocaine. These results suggest that repeated exposure to ethanol may lead to neuroadaptive changes in the dynorphin/kappa-receptor system associated with the mesolimbic pathway, some of which may be long lasting. Following repeated ethanol administration, extracellular dopamine concentrations in the nucleus accumbens were significantly increased in rats pre-treated with ethanol, but not in the controls. Conversely, the inibitory effect of the kappa-receptor agonist U50,488H on dopamine levels was more pronounced in saline- than in ethanol -pre-treated rats. This suggests that repeated ethanol changes the sensitivity of the dynorphin/kappa-receptor system, and/or enhances the activity of the endogenous agonist dynorphin. Pre-treatment with ethanol increased the effect of cocaine on dopamine levels in the nucleus accumbens. Cocaine-induced stereotypic behavior was unaffected by ethanol pre-treatment. The enhanced dopamine release in the nucleus accumbens may be related to the heightened experience produced by concurrent intake of ethanol and cocaine in humans, and could influence the probability of co- abuse. Naltrexone and the selective delta-receptor antagonists ICI-174,864 and naltrindole significantly decreased voluntary ethanol intake, whereas the mu1-antagonist naloxonazine had no significant effect. The kappa-receptor agonist U50,488H decreased ethanol intake, whereas the kappa-receptor antagonist nor-BNI lacked effect by itself, but reduced the effect of U50,488H. This suggests that not only the mu-/delta-receptor systems, but also the kappa-receptor systems modulate volitional ethanol intake in the rat.
In summary, repeated exposure to ethanol andlor cocaine produces alterations in the brain dynorphin/kappa-opioid receptor system. Further, voluntary ethanol intake is reduced by selective opioid receptor ligands. It is suggested that the dynorphinergic system is involved in the pathophysiology of alcohol dependence, and may represent a potential pharinacotherapeutic target in the treatment of this disorder.
Repeated ethanol administration significantly increased the dynorphin B levels in the nucleus accumbens at 30 min and at 21 days after the last dose. The kappa-receptor mRNA levels were significantly reduced in both the VTA and the nucleus accumbens after separate as well as concurrent administration of ethanol and cocaine. These results suggest that repeated exposure to ethanol may lead to neuroadaptive changes in the dynorphin/kappa-receptor system associated with the mesolimbic pathway, some of which may be long lasting. Following repeated ethanol administration, extracellular dopamine concentrations in the nucleus accumbens were significantly increased in rats pre-treated with ethanol, but not in the controls. Conversely, the inibitory effect of the kappa-receptor agonist U50,488H on dopamine levels was more pronounced in saline- than in ethanol -pre-treated rats. This suggests that repeated ethanol changes the sensitivity of the dynorphin/kappa-receptor system, and/or enhances the activity of the endogenous agonist dynorphin. Pre-treatment with ethanol increased the effect of cocaine on dopamine levels in the nucleus accumbens. Cocaine-induced stereotypic behavior was unaffected by ethanol pre-treatment. The enhanced dopamine release in the nucleus accumbens may be related to the heightened experience produced by concurrent intake of ethanol and cocaine in humans, and could influence the probability of co- abuse. Naltrexone and the selective delta-receptor antagonists ICI-174,864 and naltrindole significantly decreased voluntary ethanol intake, whereas the mu1-antagonist naloxonazine had no significant effect. The kappa-receptor agonist U50,488H decreased ethanol intake, whereas the kappa-receptor antagonist nor-BNI lacked effect by itself, but reduced the effect of U50,488H. This suggests that not only the mu-/delta-receptor systems, but also the kappa-receptor systems modulate volitional ethanol intake in the rat.
In summary, repeated exposure to ethanol andlor cocaine produces alterations in the brain dynorphin/kappa-opioid receptor system. Further, voluntary ethanol intake is reduced by selective opioid receptor ligands. It is suggested that the dynorphinergic system is involved in the pathophysiology of alcohol dependence, and may represent a potential pharinacotherapeutic target in the treatment of this disorder.
List of papers:
I. Franck J, Lindholm S, Raaschou P (1998). "Modulation of volitional ethanol intake in the rat by central delta-opioid receptors. " Alcohol Clin Exp Res 22(6): 1185-9
Pubmed
II. Rosin A, Lindholm S, Franck J, Georgieva J (1999). "Downregulation of kappa opioid receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral tegmentum and nucleus accumbens. " Neurosci Lett 275(1): 1-4
Pubmed
III. Lindholm S, Ploj K, Franck J, Nylander I (2000). "Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain. " Alcohol 22(3): 165-71
Pubmed
IV. Lindholm S, Werme M, Brene S, Franck J (2001). "The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat. " Behav Brain Res 120(2): 137-46
Pubmed
V. Lindholm S, Rosin A, Dahlin I, Georgieva J, Franck J (2001). "Ethanol administration potentiates cocaine-induced dopamine levels in the rat nucleus accumbens." Brain Research (In Print)
VI. Lindholm S, Rosin A, Dahlin I, Georgieva J, Franck J (2001). "Ethanol alters the effect of kappa receptor ligands on dopamine release in the nucleus accumbens." (Manuscript)
I. Franck J, Lindholm S, Raaschou P (1998). "Modulation of volitional ethanol intake in the rat by central delta-opioid receptors. " Alcohol Clin Exp Res 22(6): 1185-9
Pubmed
II. Rosin A, Lindholm S, Franck J, Georgieva J (1999). "Downregulation of kappa opioid receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral tegmentum and nucleus accumbens. " Neurosci Lett 275(1): 1-4
Pubmed
III. Lindholm S, Ploj K, Franck J, Nylander I (2000). "Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain. " Alcohol 22(3): 165-71
Pubmed
IV. Lindholm S, Werme M, Brene S, Franck J (2001). "The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat. " Behav Brain Res 120(2): 137-46
Pubmed
V. Lindholm S, Rosin A, Dahlin I, Georgieva J, Franck J (2001). "Ethanol administration potentiates cocaine-induced dopamine levels in the rat nucleus accumbens." Brain Research (In Print)
VI. Lindholm S, Rosin A, Dahlin I, Georgieva J, Franck J (2001). "Ethanol alters the effect of kappa receptor ligands on dopamine release in the nucleus accumbens." (Manuscript)
Issue date: 2001-09-28
Publication year: 2001
ISBN: 91-7349-026-1
Statistics
Total Visits
Views | |
---|---|
Neurochemical ...(legacy) | 329 |
Neurochemical ... | 135 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Neurochemical ... | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Top country views
Views | |
---|---|
United States | 115 |
Sweden | 54 |
Germany | 40 |
China | 38 |
South Korea | 13 |
Ireland | 8 |
Finland | 6 |
United Kingdom | 5 |
Russia | 5 |
Canada | 3 |
Top cities views
Views | |
---|---|
Kiez | 15 |
Seoul | 11 |
Sunnyvale | 10 |
Dublin | 8 |
Beijing | 7 |
Ashburn | 6 |
Stockholm | 6 |
University Park | 6 |
Des Moines | 5 |
Malmo | 4 |